General

Dupuytren versus Spellcheck
By: Charles Eaton
Nov 26, 2019

The word “Dupuytren” is often missing from spellcheck libraries. Before my phone got used to me, it transcribed Dupuytren as “Jupiter Den”, “Two Bedrooms” “Do engine” and other comical substitutions, although it never produced “Department Contracture” or “Dumpster Contracture”, as in this newspaper article published last week: Dupuytren, Dupuytren, Dupuytren! It’s a common problem. We need […]

Read more ›
Stop blaming the Vikings!
On: Nov 21, 2019
By: Charles Eaton

You’ve heard it: “Dupuytren is a ‘Viking disease’.” Is it? The answer begins in 1985. That year, surgeon John Hueston published his second textbook on Dupuytren disease. He wrote this on the first page of Chapter 6: That the Celtic immigration has spread this ‘Viking disease’ across the north of Europe, where the highest incidence […]

Read more ›
Dupuytren Hand Therapy Podcast 1/2
On: Nov 19, 2019
By: Charles Eaton

Susan Weiss OTR/L CHT just released the first of a 2-part audio podcast interview with Dupuytren Research Group’s Dr. Charles Eaton, discussing Dupuytren disease from a hand therapy perspective. Very interesting, can’t wait for the second installment!

Read more ›
Dupuytren Outreach Milestone
On: Oct 28, 2019
By: Charles Eaton

Dupuytren Research Group Outreach and Awareness programs have reached a new milestone: 1000 subscribers to Dupuytren.tv, the Dupuytren Research Group video podcast / YouTube channel. It’s actually a big deal: we don’t feature cats or dogs, cute babies, social media influencers, hot spokesmodels, “one weird trick” clickbait, video game reviews, celebrities behaving badly, or other […]

Read more ›
Podcast: Nine Dupuytren Questions
On: Oct 25, 2019
By: Charles Eaton

Here’s a fresh podcast reviewing the state of Dupuytren disease in 2019. In this podcast, Dr. Eaton of the Dupuytren Research Group reviews these 9 topics: What is Dupuytren Disease? Why do people develop it? What happens over time? How is it measured? How to prevent progression? How is it treated? Why is recurrence such a problem? Why is it so different […]

Read more ›
It’s Dupuytren’s Birthday!
On: Oct 5, 2019
By: Charles Eaton

Happy Birthday, Dupuytren! It may not seem that long ago, but Guillaume Dupuytren was born just 242 years ago today on Oct. 5, 1777. Dupuytren disease goes by his name because of the lecture he gave and the surgery he performed for this condition at Hôpital-Dieu in Paris on the 5th of December 1831, just […]

Read more ›
Dupuytren Rare Champion of Hope Award
On: Sep 24, 2019
By: Charles Eaton

I just returned from the 2019 Global Genes Rare Advocacy Summit with the Rare Champion of Hope award in the category of science. It was one of the most exciting and inspirational meetings I’ve attended, filled with successful disease advocates, brilliant researchers, and leaders in genomic and advocacy technologies. What I learned there will change […]

Read more ›
Dupuytren Awareness
On: Aug 23, 2019
By: Charles Eaton

Promoting Dupuytren awareness is a cornerstone of making progress toward a Dupuytren cure. The Dupuytren Research Group has been promoting Dupuytren awareness to patients and physicians for the last 10 years through social media, online videos, academic journal articles and textbooks, scientific conferences, and public awareness seminars. We’ve had limited television exposure because our financial […]

Read more ›
The Need for Nonprofit Medical Research
On: Aug 16, 2019
By: Charles Eaton

Why isn’t there a drug for Dupuytren already? You might hear that surgeons don’t want a Dupuytren cure because it’s so profitable – but take it from a hand surgeon: if Dupuytren disappeared today, surgeons would be happier than patients: no one will miss Dupuytren. So why isn’t there a drug to slow down or […]

Read more ›